AI Article Synopsis

  • Long-acting injectable antiretroviral therapy (LAI-ART) is the latest development in HIV treatment, requiring research to improve access for all individuals living with HIV.
  • Focus group discussions were held with healthcare providers in major US cities to identify barriers and facilitators for implementing LAI-ART, emphasizing organizational readiness and participant insights.
  • Key findings showed a strong commitment to equitable access to LAI-ART, the need for clinics to take on more responsibility for patient adherence, and highlighted the importance of strengthening existing systems and resources to facilitate broader implementation.

Article Abstract

Background: Long-acting injectable antiretroviral therapy (LAI-ART) represents the next innovation in HIV therapy. Pre-implementation research is needed to develop effective strategies to ensure equitable access to LAI-ART to individuals living with HIV.

Methods: We conducted focus group discussions (FGDs) with providers and staff affiliated with HIV clinics in San Francisco, Chicago, and Atlanta to understand barriers to and facilitators of LAI-ART implementation. Participants also completed a short survey about implementation intentions. FGDs were held via video conference, recorded, transcribed, and thematically analyzed using domains associated with the Consolidated Framework for Implementation Research (CFIR).

Results: Between September 2020 and April 2021, we led 10 FDGs with 49 participants, of whom ~60% were prescribing providers. Organizational readiness for implementing change was high, with 85% agreeing to being committed to figuring out how to implement LAI-ART. While responses were influenced by the unique inner and outer resources available in each setting, several common themes, including implementation mechanisms, dominated: (1) optimism and enthusiasm about LAI-ART was contingent on ensuring equitable access to LAI-ART; (2) LAI-ART shifts the primary responsibility of ART adherence from the patient to the clinic; and (3) existing clinic systems require strengthening to meet the needs of patients with adherence challenges. Current systems in all sites could support the use of LAI-ART in a limited number of stable patients. Scale-up and equitable use would be challenging or impossible without additional personnel. Participants outlined programmatic elements necessary to realize equitable access including centralized tracking of patients, capacity for in-depth, hands-on outreach, and mobile delivery of LAI-ART. Sites further specified unknown logistical impacts on implementation related to billing/payer source as well as shipping and drug storage.

Conclusions: Among these HIV care sites, clinic readiness to offer LAI-ART to a subset of patients is high. The main challenges to implementation include concerns about unequal access and a recognition that strengthening the clinic system is critical.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588099PMC
http://dx.doi.org/10.1186/s43058-023-00506-3DOI Listing

Publication Analysis

Top Keywords

equitable access
12
lai-art
10
long-acting injectable
8
antiretroviral therapy
8
access lai-art
8
implementation
6
assessing readiness
4
readiness implement
4
implement long-acting
4
hiv
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!